Nectar Lifesciences Limited (NSE:NECLIFE)

Nectar Lifesciences Statistics

Total Valuation

NSE:NECLIFE has a market cap or net worth of INR 2.35 billion. The enterprise value is 1.10 billion.

Market Cap	2.35B
Enterprise Value	1.10B

Important Dates

The last earnings date was Saturday, May 30, 2026.

Earnings Date	May 30, 2026
Ex-Dividend Date	n/a

Share Statistics

NSE:NECLIFE has 194.26 million shares outstanding. The number of shares has decreased by -2.54% in one year.

Current Share Class	194.26M
Shares Outstanding	194.26M
Shares Change (YoY)	-2.54%
Shares Change (QoQ)	-9.87%
Owned by Insiders (%)	56.26%
Owned by Institutions (%)	6.72%
Float	82.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	25.28
PB Ratio	0.40
P/TBV Ratio	0.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.37
EV / Sales	11.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.30

Financial Position

The company has a current ratio of 9.59

Current Ratio	9.59
Quick Ratio	4.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.43

Financial Efficiency

Return on equity (ROE) is -7.46% and return on invested capital (ROIC) is -6.36%.

Return on Equity (ROE)	-7.46%
Return on Assets (ROA)	-2.42%
Return on Invested Capital (ROIC)	-6.36%
Return on Capital Employed (ROCE)	-8.75%
Weighted Average Cost of Capital (WACC)	7.87%
Revenue Per Employee	52,021
Profits Per Employee	-1.64M
Employee Count	1,786
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-305.32M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.45% in the last 52 weeks. The beta is 0.66, so NSE:NECLIFE's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	-55.45%
50-Day Moving Average	11.81
200-Day Moving Average	14.46
Relative Strength Index (RSI)	45.84
Average Volume (20 Days)	354,251

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:NECLIFE had revenue of INR 92.91 million and -2.93 billion in losses. Loss per share was -13.40.

Revenue	92.91M
Gross Profit	92.91M
Operating Income	-517.54M
Pretax Income	-878.79M
Net Income	-2.93B
EBITDA	-289.51M
EBIT	-517.54M
Loss Per Share	-13.40

Balance Sheet

The company has 1.25 billion in cash and n/a in debt, with a net cash position of 1.25 billion or 6.44 per share.

Cash & Cash Equivalents	1.25B
Total Debt	n/a
Net Cash	1.25B
Net Cash Per Share	6.44
Equity (Book Value)	5.82B
Book Value Per Share	28.98
Working Capital	2.59B

Cash Flow

In the last 12 months, operating cash flow was -3.49 billion and capital expenditures -122.74 million, giving a free cash flow of -3.61 billion.

Operating Cash Flow	-3.49B
Capital Expenditures	-122.74M
Depreciation & Amortization	228.03M
Net Borrowing	-6.36B
Free Cash Flow	-3.61B
FCF Per Share	-18.58

Margins

Gross Margin	100.00%
Operating Margin	-557.04%
Pretax Margin	-945.86%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NSE:NECLIFE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.54%
Shareholder Yield	2.54%
Earnings Yield	-124.71%
FCF Yield	-153.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 12, 2008. It was a forward split with a ratio of 10.

Last Split Date	Nov 12, 2008
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	2